Envoy Medical, Inc.

COCH Nasdaq SEC CIK 1840877
Follow Envoy Medical Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $66K +57.1% vs same quarter last year
Net income −$3.9M +39.3% vs same quarter last year
EPS, diluted −$0.50 +85.9% vs same quarter last year
Operating cash flow −$5M −16.1% vs same quarter last year
Revenue by quarter
$42K
$46K
$78K
$42K
$75K
$39K
$51K
$66K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income6 fiscal years
  • Revenue
  • Net income
−$30M−$20M−$10M$0$10MFY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$241K−$23.8M
FY24$225K−$20.8M
FY23$316K−$29.9M
FY22$237K−$15.9M
FY21-−$251.6K
FY20--
MarginsShare of revenue
  • Operating margin
  • Net margin
−10000%−7500%−5000%−2500%0%FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25−9240.7%−9857.3%
FY24−8558.2%−9242.2%
FY23−5809.8%−9469%
FY22−3673.4%−6718.6%
FY21--
FY20--
Free cash flowOperating cash flow minus capital expenditure
−$20M−$15M−$10M−$5M$0FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$18.4M
FY24−$18.9M
FY23−$17.2M
FY22−$9M
FY21-
FY20-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Envoy Medical
  • Healthcare median
−10000%−7500%−5000%−2500%0%FY20FY21FY22FY23FY24FY25
Show the numbers
YearEnvoy MedicalHealthcare median
FY25−9857.3%−30.6%
FY24−9242.2%−47%
FY23−9469%−58%
FY22−6718.6%−80.4%
FY21-−71.8%
FY20-−62.2%